Fig. 3From: Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patientsImprovement in FEV1 AUC0-4h (mL) with indacaterol maleate and indacaterol acetate versus placebo at Day 14. Data presented as LS mean treatment differences (95% CI). AUC, area under the curve; CI, confidence interval; FEV1, forced expiratory volume in 1 s; LS, least square; N, number of patientsBack to article page